Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

FDC drugs are those that contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also ...

Scientists explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.

FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

CDSCO directs States to halt sale of unapproved FDC drugs, emphasizing safety and compliance with drug regulations.